Showing 1 - 10 of 13
Persistent link: https://www.econbiz.de/10011527417
This paper integrates innovation input and output effects of R&D subsidies into a modified Crépon–Duguet–Mairesse (CDM) model. Our results largely confirm insights of the input additionality literature, i.e. public subsidies complement private R&D investment. In addition, results point to...
Persistent link: https://www.econbiz.de/10011487998
Persistent link: https://www.econbiz.de/10009130053
Persistent link: https://www.econbiz.de/10003630786
In this contribution we describe how green policies should be designed to activate private innovation forces for ecological transitions. We look at the evidence on the current deployment of green policies and the current performance of the private green innovation machine. We try to assess how...
Persistent link: https://www.econbiz.de/10011336729
This contribution focuses on the heterogeneity in innovation capacity within Europe across its different Member State. Who are the leading and who are the lagging EU countries? Is there a trend towards convergence over time? And how has the crisis affected this trend of convergence? We then take...
Persistent link: https://www.econbiz.de/10011341216
This paper evaluates the current focus of EU policy makers on small and medium-sized, young independent firms in high-tech sectors. Therefore, the effect of subsidies on both R&D input and R&D output is compared between independent high-tech young firms (NTBFs), independent low-tech young firms...
Persistent link: https://www.econbiz.de/10010519610
Persistent link: https://www.econbiz.de/10011290621
Concern exists that public funding of science is increasingly risk averse. Funders have addressed this concern by soliciting the submission of high-risk research to either regular or specially designed programs. Little evidence, however, has been gathered to examine the extent to which such...
Persistent link: https://www.econbiz.de/10013361975
The speed with which Covid-19 vaccines were developed and their high-performance underlines how much society depends on the pace of scientific research and how effective science can be. This is especially the case for vaccines based on the new designer mRNA technology. We draw on this...
Persistent link: https://www.econbiz.de/10012585389